Our hatchery, where annually 12,000,000 to 13,000,000 day-old baby chicks can be hatched, has started to operate on 1st October, 2013.
Our new hatchery is equipped with new Pas Reform machines. We have 12 Pas Reform Smart SetPro incubators, and 9 Pas Reform Smart HatchPro hatchers.
In line with the demands of our partners and the market, our company, striving for the highest possible quality and a wide spectrum of services, has made a new investment in its Hatchery at the end of 2014. We can now vaccine the day-old chicks using an in-ovo machine. The Embrex system, we use, is the world's most popular in-ovo vaccination technology.
The machine’s vaccination head can match the position of the eggs not just vertically, but also horizontally. The double needle concept increases efficiency even further: the piercing needle serving to pierce the egg shell remains above the air chamber, only the vaccination needle enters the proper parts of the eggs. So disinfection is perfect between each vaccination cycle, which prevents contamination among the eggs.
The benefits of in-ovo vaccination:
Greater consistency in vaccination: approximately 100% of the chicks receive their full dose of the vaccine.
The quality of vaccination is improved: the right dose to the right place at the right time.
Early protection (the multiplication of the vaccine virus may begin 3 days before hatching)
Less stress in the day-old age
Minimal day-old death.
The benefits of in-ovo vaccination against Gumboro disease using the Transmune vaccine:
Uniform immunity within the flock: each bird (embryo) receives the proper, i.e. the total dose. During live vaccination in farms, only 70-80% of the birds are vaccinated in most cases, the other birds remain susceptible to the disease, and can pass on the virus.
Early protection: because the vaccine is administered three days before hatching, the body of the birds may expect any possible infection much earlier and more prepared.
Given the fact that the Transmune is an immuncomplex vaccine, there is no interference with maternal antibodies. The release of the vaccine virus from the complex (i.e. immunization) occurs at relatively low levels of MDA, depending on the natural decrease in the maternally derived antibodies (MDA).
As seen in the previous paragraph, there is no need to determine the optimal time of vaccination on the farm from the titer values of the maternal antibodies of the baby chicks against the Gumboro disease.
In some cases, when the dispersion of the titer values is high, two successive vaccinations may be required to achieve the appropriate level of immunity. Using the Transmune in an in-ovo manner, the level of the antibodies is "synchronized" in the birds, so this potential is not to be expected.
No vaccination is needed against the Gumboro disease on the farm, which requires less work from the farm workers.
The vaccination in the drinking water - although this fact is not often considered - requires quite a lot of care and expertise. The in-ovo vaccination removes this problem from the shoulders of the owners.
Vaccines in the in-ovo technology:
Vaccines against: Marek, Gumboro disease (IBD), Newcastle disease (Newcastle), Avian influenza (AI), Coccidiosis and infectious laryngeal and tracheal inflammation (ILT).
In addition to its existing vehicles, our company, in preparation for the long-term deliveries, has purchased a new VEIT 40 day-old chick transport vehicle in 2016, which is capable of transporting 130,000 chicks safely.